Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Phase 2a > Conditions - Resp > Flashcards

Conditions - Resp Flashcards

(56 cards)

Start Studying
1
Q

COPD definition

A

It is a NON-reversible, long-term, progressive lung disease characterised by airway obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COPD encompasses which two types of chronic lung disease?

A

Chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COPD epidemiology

A
  • 2% of the UK population are living with DIAGNOSED COPD
  • Each year is accounts for 26% of all lung disease related deaths
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COPD aetiology

A
  • Smoking (active and passive)
  • Occupational exposures e.g., mining (v common in Sheffield), cotton, wool, dust
  • Alpha-1 antitrypsin deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alpha-1 antitrypsin in COPD

A

Alpha-1 antitrypsin deficiency can lead to earlier onset and increased severity of COPD. Alpha-1 antitrypsin is an inhibitor of proteinases enzymes. It is produced in the liver and protects the lung from enzymes which are secreted by neutrophils in response to infection and irritants. The lack of sufficient levels of AAT leads to lung damage by the proteinase enzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is chronic bronchitis?

A

Involves hypertrophy and hyperplasia of the mucus glands in the bronchi.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is emphysema?

A

Involves enlargement of the air spaces and destruction of alveolar walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COPD clinical presentation

A

Dyspnoea
Cough
Sputum production
Wheeze
Cyanosis
Recurrent respiratory infections
Reduced exercise tolerance
Weight loss
Accessory muscle use for respiration
Pursed lip breathing
Tachypnoea
Reduced chest expansion
Hyper-resonant percussion
Decreased/quiet breath sounds
Cor pulmonale (signs of RHF)
Prolonged expiratory phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COPD investigations

A

Spirometry showing FEV1/FVC < 0.7
CXR showing a flattened diaphragm
Serum A1AT levels
FBC
BMI
ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COPD management

A

Stop smoking (if smoking)
Lifestyle changes
SABA (salbutamol) or SAMA (ipratropium bromide)

If no asthmatic/steroid response: LABA (salmeterol) or LAMA (tiotropium bromide)
If asthmatic/steroid response: LABA (salmeterol) or inhaled corticosteroids

Long-term oxygen therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MRC Dyspnoea Scale

A

0 - I only get breathless with strenuous exercise
1 - I get short of breath when hurrying on level ground or walking up slight hills
2 - on level ground, I walk slower than people my age because of breathlessness, or I have to stop for breath when walking at my own pace on level
3 - I stop for breath after walking about 100 yards or after a few minutes on level ground
4 - I am too breathless to leave the house or I am breathless when dressing/undressing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Asthma pathology

A

Chronic inflammation of the airways caused by IgE mediated type I hypersensitivity causing episodic exacerbations of bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Asthma triggers

A

Infection
Night time/early morning (diurnal variability)
Exercise
Animals
Damp/Cold
Dust
Strong emotions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Asthma clinical presentation

A

Episodic symptoms
Diurnal variability
Dry cough with wheeze and SOB
History of atopic conditions (eczema, hayfever, asthma)
Bilateral widespread “polyphonic” wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Asthma investigations

A

Fractional exhaled nitric oxide
Spirometry showing FEV1/FVC < 0.7
Spirometry with bronchodilator reversibility
Peak flow variability (measured several times per day for 2 weeks)
Direct bronchial challenge test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Asthma management (ongoing)

A

Step 1 - SABA (salbutamol)
Step 2 - SABA + inhaled corticosteroids (beclometasone)
Step 3 - SABA + ICS + LABA (salmeterol)
Step 4 - SABA + LABA + high-dose corticosteroids + considering leukotriene receptor antagonists (montelukast / modified-release theophylline) or LAMA (tiotropium bromide
Step 5 - SABA + LABA + high-dose ICS + daily oral low-dose corticosteroids (prednisolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Asthma management (acute)

A

ABCDE O SHIT ME
ABCDE
Oxygen
Salbutamol (nebulised)
Hydrocortisone IV or oral prednisolone
Ipratropium bromide (SAMA)
Theophylline (leukotriene receptor antagonist)
Magnesium sulphate
Escalate care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TB pathology

A
  • Type IV hypersensitivity reaction
  • Results in caseating granulomas
  • Airborne spread through droplets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TB aetiology

A

Mycobacterium Tuberculosis
(Acid-fast bacilli)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

TB risk factors

A
  • Known contact with active TB
  • Immigrants from areas of high TB prevalence e.g. South Asia and Africa
  • Immunosuppression e.g. HIV
  • Homeless people, drug users, alcoholics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TB clinical presentation

A

Lethargy
Fever/night sweats
Weight loss
Cough +/- haemoptysis
Lymphadenopathy
Spinal TB -> Erythema nodosum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TB investigations

A

2 tests for an immune response to TB
- Mantoux test (Tuberculin skin testing, >5mm or more = positive)
- Interferon-Gamma Release Assays

CXR

Sputum Culture
- Ziehl-Neelsen Stain -> Bright red
- Cultured with Lowenstein-Jensen Medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TB management (active)

Study These Flashcards
A

Combination of Antibiotics (+ their SE)
- Rifampicin - 6 months
- Isoniazid - 6 months
Pyrazinamide - 2 months
Ethambutol - 2 months

SE management - Pyridoxine (Vit B6)

24
Q

TB management side effects

Study These Flashcards
A

Rifampicin - red urine/tears (“red-I’m-pissin’”)
Isoniazid - peripheral neuropathy (“I’m-so-numb-azid”)
Pyrazinamide - hyperuricemia - Gout
Ethambutol - colour blindness, decreased visual acuity (“eye-thambutol”)

25
TB prevention
BCG vaccination
26
Pneumonia definition
Infection-induced inflammatory condition of the lungs
27
Pneumonia pathology
Invasion and overgrowth of a pathogen in the lung parenchyma which overwhelms host immune defenses and leads to the production of intra alveolar exudates (which then block the alveoli, impairing gas exchange due to reduced ventilation).
28
Pneumonia clinical features (symptoms)
Fever Cough Haemoptysis Purelent sputum Rigors Low blood pressure Dyspnoea Malaise Pleuritic chest pain (sharp chest pain worse on inspiration) Sepsis
29
Pneumonia types
- Community-acquired - Hospital-acquired - Atypical - Aspiration - Pneumonia in immunocompromised patients
30
Pneumonia clinical features (signs)
Dull to percussion (due to lung collapse and/or consolidation) Decreased air entry Bronchial breath sounds (harsh breath sounds which are equally loud of inspiration and expiration- due to consolidation of the lung tissue) Tachypnoea Tachycardia Hypoxia Hypotension Increased vocal resonance/ tactile vocal fremitus (due to air passing through the sputum in the airways) Confusion Cyanosis
31
Pneumonia aetiology
Streptococcus pneumoniae (50%) Haemophilus influenzae (20%)
32
Pneumonia investigations
ABG CXR showing consolidation Sputum for microscopy and culture Blood culture Bloods including FBC, U&E, ESR, CRP
33
Pneumonia severity score
CURB-65 1 point for each of the following: Confusion Urea >7 Respiratory rate ≥30 Blood pressure <90 and/or ≤60 diastolic Age ≥65 0-1= outpatient treatment 2= short stay inpatient or hospital supervised outpatient treatment 3-5= manage as high severity pneumonia
34
Pneumonia management
Want to maintain oxygen sats between 94-98% (note: in COPD patients want to maintain oxygen sats between 88-92%) Use analgesia IV fluids CURB-65 guided treatments: 0-1: oral amoxicillin 2: amoxicillin (IV/ oral) and macrolide (clarithromycin or erythromycin) 3+: IV co-amoxiclav and macrolide (clarithromycin or erythromycin)
35
Hospital-acquired pneumonia
This is a lower respiratory tract infection that develops more than 48 hours after hospital admission. The most common organisms are Pseudomonas aeruginosa, Staphylococcus aureus and enterobacteria.
36
Aspiration pneumonia
This occurs in patients with an unsafe swallow. Risk factors include stroke, myasthenia gravis, bulbar palsy, alcoholism and achalasia. On chest x-ray the right lung is most commonly affected, as the right bronchus is wider and more vertical than the left bronchus, making it more likely to facilitate the passage of aspirate.
37
Atypical pneumonia
Bacterial pneumonia caused by atypical organisms that can’t be detected on a gram stain and can’t be cultured using standard methods.
38
Legionella pneumonia
It is associated with Legionnaire’s disease, usually in patients who have been exposed to poor hotel air con. Note: can cause hyponatreamia.
39
Pneumocystis pneumonia
Associated with patients who are immunosuppressed (malignancy or chemotherapy) or HIV positive. The causative organism is called pneumocystis jiroveci and is a fungus. In patients who are HIV positive the risk of PCP increases when the CD4+ <200 cells/uL. Patient will have symptoms such as a fever, dry cough and exertional dyspnoea.
40
Pneumonia treatment in patients with a penicillin allergy
Doxycycline (moderate severity) Clarithromycin (moderate severity) Levofloxacin (high severity)
41
Cystic fibrosis aetiology
Autosomal recessive condition caused by a mutation of the CFTR gene on chromosome 7
42
Cystic fibrosis pathology
Affects mucous glands, causing the glands to produce thick secretions
43
Cystic fibrosis clinical features (1st sign)
Meconium ileus Meconium not passed within 48 hours of birth + abdominal distention and vomiting
44
Cystic fibrosis clinical features (symptoms)
Chronic cough Loose, greasy stools (steatorrhea) Failure to thrive Thick sputum production Recurrent respiratory tract infections Salty skin
45
Cystic fibrosis clinical features (signs)
Nasal polyps Finger clubbing Crackles + Wheeze Abdominal distention
46
Cystic fibrosis complications
Infertility (congenital bilateral absence of vas deferens in males) Pancreatitis Diabetes Respiratory tract infections Bronchiectasis
47
Cystic fibrosis investigations
Newborn bloodspot test (screening) Sweat test Genetic testing for CFTR gene
48
Cystic fibrosis key colonisers
Staph aureus (take prophylactic flucloxacillin) Pseudomonas aeruginosa (hard to treat + worsens prognosis, take long term nebulised antibiotics)
49
Cystic fibrosis management
No cure, LE=50 Chest Physio Exercise High calorie diet CREON tablets Treat chest infections Bronchodilators Nebulised DNase- makes secretions less viscous Nebulised hypertonic saline Novel Triple Therapy Vaccinations Lung/Liver transplant
50
Bronchiectasis main organisms
H. influenzae Pseudomonas aeruginosa Strep. pneumoniae
51
Bronchiectasis aetiology
- End point/complication of many lung disease e.g. COPD, CF - Post-infection (most common), eg. previous pneumonia or TB - Congenital, eg. CF and primary ciliary dyskinesia
52
Bronchiectasis pathology
- Chronic inflammation of the bronchi and bronchioles leading to permanent dilation and thickening of these airways - Build up of mucus, increased risk of infections
53
Bronchiectasis clinical features (symptoms)
Persistent cough Copious purulent sputum Intermittent haemoptysis Dyspnoea
54
Bronchiectasis clinical features (signs)
Finger clubbing Coarse inspiratory crepitations recurrent infections
55
Bronchiectasis investigations
High-resolution CT (Gold Standard) Sputum culture to show infection CXR showing cystic shadows, thickened bronchial walls Spirometry Bronchoscopy
56
Bronchiectasis management
Can’t be cured Non-Pharmacological - Stop smoking - Vaccinations - Airway clearance techniques Pharmacological - Mucolytic - Carbocysteine - Antibiotics - Bronchodilators e.g. nebulised salbutamol - Corticosteroids e.g. prednisolone Surgery - may be indicated in localised disease or to control severe haemoptysis

Phase 2a (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions